Khanna Khanna

Dr. Khanna Khanna


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2023 in Case Reports in Neurology
Verified
Journal Article
Open access
PDF file
KKKhanna Khanna
Khanna Khanna
SPSuchita Pant
Suchita Pant
HKHarsh Khanna
Harsh Khanna
Isoniazid is one of the most important drugs in the management of pulmonary tuberculosis; of all the antituberculous drugs, it is one of the most commonly implicated drugs in drug-induced psychosis. We report a case of isoniazid-induced psychosis in a 31-year-old patient with pulmonary tuberculosis.

28 April 2025
Verified
Book Chapter
Open access
PDF file
KKKhanna Khanna
Khanna Khanna
Psychosis is a severe and a complicated mental disorder that affects the overall well-being of an individual through alterations in thought and perceptions wherein the person losses touch with reality. The symptomatology of the disorder is demarcated as positive and the negative symptoms. The positive symptoms including delusions, illusions, auditory hallucinations, and thought disorders are the additional behaviors that develop after an individual develops the illness whereas the negative symptoms include introverted behavior, poor sociability, emotional blunting, amotivation, and cognitive deficits that reflect a decline in the normal functioning capacity of the person. People with psychotic disorders exhibit a significant reduction in the overall quality of life particularly in the domains of physical and mental health, social intercourses, self-esteem, and interpersonal relationships. Psychotic disorders are also one of the leading causes of disability and disability adjusted life years (DALYs) globally, causing a dent in the economy of a country through the inherent direct healthcare costs and the indirect costs (productivity and income losses) causing a depletion in capital and labor resource pool and subsequently causing a decrease in the overall productive capacity of the country. The existing literature highlights the importance of early interventions in psychosis, community-based multidisciplinary approaches including cognitive behavior therapy, somatic interventions, and pharmacotherapy in curtailing the impact and ameliorating the overall quality of life in people with psychosis.

24 April 2024
Verified
Book Chapter
Open access
PDF file
KKKhanna Khanna
Khanna Khanna
Schizophrenia is a serious mental health disorder that affects a person’s overall well-being. It is a functional psychosis in which severe personality changes and thought disorders occur with no evidence of organic cerebral damage. The disease manifestation primarily includes the presence of two types of symptoms “positive” and “negative.” Positive symptoms include delusions, illusions, auditory hallucinations, thought disorders with irrational conclusions, poor sentence formation, and stereotypic or aggressive behavior, whereas negative symptoms include withdrawn behavior, poor socialization, emotional dampening, absence of enthusiasm, and cognitive deficits. Usually, the onset is at the age of 15–30 years. Starting treatment as early as possible is an important step in the recovery process. Cognitive symptoms include problems in attention, concentration, and memory. Antipsychotic medications can help to alleviate the frequency and intensity of psychotic symptoms. These medications are usually taken in tablet or liquid form on a daily basis. Some antipsychotic medications are given as injections at intervals of 2–4 weeks. Psychosocial treatments help people find solutions to everyday challenges and manage symptoms while attending school, working, and forming relationships. Educational programs can help family and friends learn about symptoms of schizophrenia, treatment options, and strategies for helping loved ones with the illness.

30 July 2025 in Cureus
Verified
Journal Article
Open access
PDF file
KKKhanna Khanna
Khanna Khanna
MMMayank Malik
Mayank Malik
RARazi Ahmad
Razi Ahmad
MSMayank Malik Sr.
Mayank Malik Sr.
Background Type 2 diabetes (T2D) represents one of the most common metabolic disorders globally. Insulin resistance is a fundamental issue associated with the disorder, wherein cells in the adipose tissue, liver, and muscle resist the action of insulin, leading to dysregulation of glucose metabolism. T2D is a known, significant, and independent risk factor for the development and progression of dyslipidemia, a condition characterized by abnormal lipid levels in the blood. Inadequately controlled T2D can lead to dyslipidemia through various mechanisms. Dyslipidemia, i.e., alteration in the levels of plasma lipids typically characterized by increased levels of triglycerides (TGs), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and low levels of high-density lipoprotein cholesterol (HDL-C), is a significant and modifiable risk factor in the development of atherosclerotic cardiovascular disease (ASCVD). Materials and methods In this prospective, observational, parallel-group, open-label study, 383 patients of inadequately controlled T2D receiving metformin (500-2000 mg) were randomized to receive vildagliptin (group A) or dapagliflozin (group B) for a 24-week duration. We compared the effects of vildagliptin and dapagliflozin on hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), and lipid profile at baseline and after 24 weeks of therapy. Results A total of 248 patients with T2D completed the follow-up for 24 weeks (mean age: 53.8±8.4 years, and the mean body mass index {BMI} was 25.0±3.4 kg/m2). From the baseline to 24 weeks, the HDL-C increased by 1.1 mg/dL in group A and by 3.17 (95% CI: 3.0-7.1) mg/dL in group B (p=0.03). A significant decrease in the mean LDL-C levels by 11.8 (95% CI: -2.10, -16.6) mg/dL was observed in group A, whereas an increase in the levels of mean LDL-C by 6.4 (95% CI: 6.1, 6.69) mg/dL in group B (p=0.03) was observed. There was no significant difference in the mean change from baseline in the HbA1c levels (-0.71 vs. -1.08, p=0.65) and in the levels of TC (p=0.87), TG (p=0.37), apolipoprotein A (p=0.986), apolipoprotein B (p=0.563), and lipoprotein(a) (p=0.767) between the vildagliptin and the dapagliflozin group after 24 weeks of therapy. Conclusions In conclusion, both vildagliptin (a DPP-4i) and dapagliflozin (an SGLT2i), when added to metformin, showed comparable efficacy in controlling plasma glucose in patients with inadequately controlled type 2 diabetes. However, they had differing effects on lipid profiles and body weight. Vildagliptin led to greater reductions in LDL-C, suggesting its preference in patients with elevated LDL-C levels. In contrast, dapagliflozin may be more suitable for obese patients with low HDL-C. Thus, adding either drug to metformin not only improves glycemic control (FPG and HbA1c) but also favorably influences lipid profiles, potentially reducing ASCVD risk in this population.

18 April 2025
Verified
Journal Article
Open access
PDF file
KKKhanna Khanna
Khanna Khanna
SDShikha Dwivedi
Shikha Dwivedi
ACAnnwesha Chaudhury
Annwesha Chaudhury
AJAyush Jain
Ayush Jain
Background: A prescription, is a written communication from a physician to the pharmacist, instructing them to deliver specific prescription drug/s for the specific patient. Prescription audits are fundamental in upholding the hospital's high standards for patient care. Aim: The purpose of this observational cross-sectional study was to review, screen, and analyze the prescriptions from the Department of Orthopedics at a Medical College Teaching Hospital in Dehradun, Uttarakhand, and to identify and resolve the low-scoring characteristics to augment the prescription quality of our Centre. Methodology: The Prescriptions were analyzed in the Department of Pharmacology associated with the Teaching Hospital, Dehradun, Uttarakhand, in terms of legibility, and completeness in terms of prescribers’, patients, and drug information using the WHO core prescribing indicators. The collected data was analyzed in Microsoft Excel. Results: The total number of prescriptions analyzed was 750, containing a total of 2588 drugs i.e. on average 3.45 drugs per prescription. More than 42% of the prescriptions lacked the duration of therapy. Allergic history was lacking in more than 75% of the prescriptions. Cholecalciferol D3 was the most commonly prescribed drug in 482 patients (64.3%) whereas, Aceclofenac was the most commonly prescribed NSAID in 128 patients (17.6%) followed by Paracetamol and Etoricoxib in about 15.7% and 15.3% respectively. About 71% of prescriptions were deemed to be of excellent legibility. Conclusion: This study helped us understand the role of prescribing the drugs by their generic names and standard treatment guidelines. To raise the standard of patient care, we strongly advise that similar research be carried out to educate medical faculty on judicious prescribing.

7 January 2025
Verified
Book Chapter
Open access
PDF file
KKKhanna Khanna
Khanna Khanna
Sleep is a very integral part of our functioning with normal adults sleeping for about 1/3rd of their lives. Sleep disorders are a group of conditions that alter the ability of a person to get appropriate sleep which can alter the day-to-day functioning. In the present day and age sleep disorders irrespective of the reason the growth in the sleep disorders is alarming. Although many people tend to experience sleep disturbances on an occasional basis owing to stressful life situations, alterations in job schedules, traveling, and many other external influences, but when these issues occur regularly and become an impedance in the day-to-day activities, it may be suggestive of a sleeping disorder. A deficiency of a good quality sleep can have overall undesirable consequences on the vitality, temperament, attentiveness, and well-being of an individual. Sleep difficulties are linked to both physical and emotional problems. Sleep problems can both contribute to and exacerbate existing mental problems as well as serve as an important indicator of other mental health conditions. While the various sleep problems may resolve on its own or eventually conclude after a successful course of therapy, in a few resistant cases the treatment normally involves a combination of medical treatments and lifestyle changes.